Found: 17
Select item for more details and to access through your institution.
Splicing Modulation via Antisense Oligonucleotides in Recessive Dystrophic Epidermolysis Bullosa.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 2, p. 761, doi. 10.3390/ijms25020761
- By:
- Publication type:
- Article
Biomarker Discovery in Rare Malignancies: Development of a miRNA Signature for RDEB-cSCC.
- Published in:
- Cancers, 2023, v. 15, n. 13, p. 3286, doi. 10.3390/cancers15133286
- By:
- Publication type:
- Article
A Novel Fluorescence-Based Screen of Gene Editing Molecules for Junctional Epidermolysis Bullosa.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Topical Diacerein Decreases Skin and Splenic CD11c + Dendritic Cells in Psoriasis.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 5, p. 4324, doi. 10.3390/ijms24054324
- By:
- Publication type:
- Article
COL7A1 Editing via RNA Trans -Splicing in RDEB-Derived Skin Equivalents.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 5, p. 4341, doi. 10.3390/ijms24054341
- By:
- Publication type:
- Article
5′RNA Trans -Splicing Repair of COL7A1 Mutant Transcripts in Epidermolysis Bullosa.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 3, p. 1732, doi. 10.3390/ijms23031732
- By:
- Publication type:
- Article
Transcriptome-Guided Drug Repurposing for Aggressive SCCs.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 2, p. 1007, doi. 10.3390/ijms23021007
- By:
- Publication type:
- Article
Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans -Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 1, p. 575, doi. 10.3390/ijms23010575
- By:
- Publication type:
- Article
Impact of low-dose calcipotriol ointment on wound healing, pruritus and pain in patients with dystrophic epidermolysis bullosa: A randomized, double-blind, placebo-controlled trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Epigenetic and metabolic regulation of epidermal homeostasis.
- Published in:
- Experimental Dermatology, 2021, v. 30, n. 8, p. 1009, doi. 10.1111/exd.14305
- By:
- Publication type:
- Article
Profiling trial burden and patients' attitudes to improve clinical research in epidermolysis bullosa.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A cancer stem cell-like phenotype is associated with miR-10b expression in aggressive squamous cell carcinomas.
- Published in:
- Cell Communication & Signaling, 2020, v. 18, n. 1, p. 1, doi. 10.1186/s12964-020-00550-9
- By:
- Publication type:
- Article
Low-dose calcipotriol can elicit wound closure, anti-microbial, and anti-neoplastic effects in epidermolysis bullosa keratinocytes.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-31823-6
- By:
- Publication type:
- Article
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 455, p. 1, doi. 10.1126/scitranslmed.aas9668
- By:
- Publication type:
- Article
RNA Trans-Splicing Modulation via Antisense Molecule Interference.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 3, p. 762, doi. 10.3390/ijms19030762
- By:
- Publication type:
- Article
The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 3, p. 361, doi. 10.1007/s00277-013-1967-y
- By:
- Publication type:
- Article
Differential Bone Marrow Homing Capacity of VLA-4 and CD38 High Expressing Chronic Lymphocytic Leukemia Cells.
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0023758
- By:
- Publication type:
- Article